Manufacturing facility
Kiniksa Pharmaceuticals (UK), Ltd., London (UK), Zweigniederlassung Zug
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Switzerland
- Registered address
- Grafenaustrasse 5, Zug, Zug 6300, Switzerland (CHE)
- Operations here
- analysis
- FDA identifiers
- FEI 3041695195 · DUNS 480625900
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- rilonaceptKiniksa Pharmaceuticals (UK), Ltd.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.